Why Is Afrezza So Hard to Find? [Explained for 2026]

If You Can't Find Afrezza, You're Not Alone

You've got your prescription in hand. You've called your pharmacy. And they don't have it. Sound familiar? If you've been trying to fill a prescription for the Afrezza 180 Titration Pack- 60, 60, 60, you already know how frustrating it can be to track down this medication.

Afrezza is one of the most unique diabetes medications on the market — an inhaled insulin that works in minutes. But that uniqueness also makes it harder to find than a typical prescription. Let's break down why.

What Is Afrezza?

Afrezza is a rapid-acting inhaled insulin made by MannKind Corporation. Unlike traditional injectable insulins, Afrezza is breathed in through a small, portable inhaler at the beginning of each meal. It's approved by the FDA to improve blood sugar control in adults with type 1 and type 2 diabetes.

The 180 Titration Pack contains single-use cartridges (a combination of 4-unit, 8-unit, and 12-unit cartridges) that let you and your doctor find the right mealtime dose. It's a game-changer for people who want to avoid needles — but getting your hands on it can be a challenge.

Why Is Afrezza So Hard to Find?

1. It's a Specialty Medication With a Single Manufacturer

Afrezza is made exclusively by MannKind Corporation. There is no generic version of Afrezza available. When you have only one company producing a drug, any hiccup in manufacturing, packaging, or distribution can cause supply problems across the country.

2. Most Pharmacies Don't Stock It Regularly

Because Afrezza is a niche product — an inhaled insulin — many chain pharmacies don't keep it on their shelves. It's not like insulin pens or vials that pharmacies order in bulk. Pharmacies often need to special-order Afrezza, which can add days or even weeks to your wait time.

3. Insurance Barriers Limit Demand (and Stocking)

Many insurance plans place Afrezza on a specialty tier or require prior authorization before they'll cover it. Some plans require step therapy, meaning you have to try and fail on injectable insulin first. These hoops reduce the number of patients filling Afrezza prescriptions, which in turn gives pharmacies less reason to keep it in stock.

4. Storage and Handling Requirements

Afrezza cartridges need to be stored properly and the inhaler device must be replaced every 15 days. These requirements make inventory management more complicated for pharmacies compared to standard insulin products.

What You Can Do About It

The good news is that Afrezza is still being manufactured and distributed. Here are some steps you can take:

• Use Medfinder to check which pharmacies near you have Afrezza 180 Titration Pack in stock right now.
• Call independent pharmacies. They're often more willing to order specialty medications and may already stock Afrezza for their patients.
• Ask your doctor's office for help. Many endocrinology offices have relationships with specialty pharmacies that regularly carry Afrezza.
• Look into the AfrezzaAssist program from MannKind, which can help with access and affordability.

For more tips, read our guide on how to find Afrezza in stock near you.

Final Thoughts

Afrezza is a valuable option for people with diabetes who prefer inhaled insulin over injections. But between single-manufacturer supply, low pharmacy stocking rates, and insurance hurdles, finding the 180 Titration Pack can take real effort.

Don't give up. Tools like Medfinder exist specifically to help you locate medications that are hard to find. And if Afrezza truly isn't available in your area, talk to your doctor about alternative rapid-acting insulins that might work for you in the meantime.